Clinical Trials Sponsored by ImmunoMet Therapeutics, Inc.
Total 3027 results
-
ImmunoMet Therapeutics, Inc.CompletedAdvanced Solid TumorKorea, Republic of
-
Immunomic Therapeutics, Inc.Active, not recruiting
-
Immunomic Therapeutics, Inc.Completed
-
Immunomic Therapeutics, Inc.Completed
-
Immunomic Therapeutics, Inc.Completed
-
Immunomic Therapeutics, Inc.CompletedAllergic RhinoconjunctivitisUnited States
-
Astellas Pharma IncImmunomic Therapeutics, Inc.Completed
-
Astellas Pharma IncImmunomic Therapeutics, Inc.Completed
-
University of FloridaImmunomic Therapeutics, Inc.Terminated
-
ImmuneMed, Inc.Not yet recruitingModerate to Severe Rheumatoid ArthritisNetherlands
-
ImmuneMed, Inc.Completed
-
ImmuneMed, Inc.CompletedHealthy VolunteersAustralia
-
ImmunoGen, Inc.CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Belgium, Spain, Israel, Australia, Ireland, Germany, Italy, Bulgaria, Czechia, Poland
-
Immunotec Inc.CompletedEffect of Immunocal® With Exercise Versus Casein With Exercise on Aging Processes in Elderly PersonsSarcopenia | AgingCanada
-
ImmunoGen, Inc.CompletedMultiple MyelomaUnited States, Argentina
-
ImmunoGen, Inc.RecruitingFallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal Carcinoma | High Grade Serous Adenocarcinoma of OvaryUnited States
-
ImmunoGen, Inc.Active, not recruitingFallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Ovarian CancerUnited States, United Kingdom, Belgium, Spain, Canada, Georgia
-
ImmuneMed, Inc.Terminated
-
ImmunoGen, Inc.Active, not recruitingBlastic Plasmacytoid Dendritic Cell Neoplasm | Myeloproliferative NeoplasmUnited States, Spain, Germany, Italy, France, United Kingdom
-
ImmuneMed, Inc.CompletedCOVID-19Italy, Russian Federation
-
ImmunoGen, Inc.TerminatedSmall Cell Lung CancerUnited States, Spain, Canada, United Kingdom
-
ImmunoGen, Inc.Completed
-
ImmunoGen, Inc.CompletedSmall Cell Lung CancerUnited States
-
ImmunoGen, Inc.Not yet recruitingRecurrent Ovarian Cancer | Folate Receptor-Alpha PositiveUnited States, Spain, Australia, Belgium, Canada, France, Ireland, Italy
-
ImmuneMed, Inc.RecruitingChronic Hepatitis BKorea, Republic of
-
Immunotec Inc.RecruitingMild Cognitive Impairment (MCI)Canada
-
ImmunoGen, Inc.Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, France, Belgium, Spain, Ireland, Italy, Australia, Canada
-
ImmunoGen, Inc.CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Belgium, Canada
-
ImmuneMed, Inc.CompletedHealthyKorea, Republic of
-
ImmunoGen, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
ImmunoGen, Inc.CompletedLymphoma, Non-Hodgkin | Chronic Lymphocytic LeukemiaUnited States, Switzerland
-
ImmunoGen, Inc.TerminatedEGFR Positive Solid TumorsUnited States
-
ImmunoGen, Inc.WithdrawnStomach Neoplasms | Metastatic or Locally Advanced Gastric Cancer | Metastatic or Local Advanced GE Junction CancerUnited States
-
ImmunoGen, Inc.CompletedOvarian Cancer | SCLC | Merkel Cell CarcinomaUnited States, United Kingdom
-
Immunotec Inc.TerminatedNON-SMALL CELL LUNG CANCERCanada
-
ImmunoGen, Inc.Completed
-
ImmunoGen, Inc.CompletedPancreatic Cancer | Non-colorectal CancerUnited States
-
ImmunoGen, Inc.MacroGenicsCompletedAdvanced Solid TumorUnited States, Italy, Spain
-
ImmunoGen, Inc.Jazz PharmaceuticalsActive, not recruitingAcute Myeloid LeukemiaUnited States, Germany, France, Spain, Italy, United Kingdom
-
ImmunoGen, Inc.GOG FoundationRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Korea, Republic of, Spain, Australia, Canada, United Kingdom, Italy, Czechia, Philippines, Israel, Belgium
-
ImmunoGen, Inc.Gynecologic Oncology GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France, Canada, Spain, Switzerland, Belgium, Italy, United Kingdom, Ireland, Russian Federation, Bosnia and Herzegovina, Czechia, Serbia
-
Nova Southeastern UniversityImmunotec Inc.CompletedAutism Spectrum DisordersUnited States
-
BayerImmunoGen, Inc.; MorphoSys AGCompletedNeoplasmsUnited States, Spain, United Kingdom, Korea, Republic of, Canada, France, Belgium, Australia, Singapore, Italy, Netherlands, Switzerland
-
University of OklahomaImmunoGen, Inc.WithdrawnEndometrial Cancer | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial AdenocarcinomaUnited States
-
Immunome, Inc.United States Department of DefenseRecruiting
-
Alessandro SantinImmunoGen, Inc.RecruitingEndometrial CancerUnited States
-
M.D. Anderson Cancer CenterImmunoGen, Inc.Completed
-
Fred Hutchinson Cancer CenterImmunoGen, Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative Neoplasm | Mixed Phenotype Acute LeukemiaUnited States
-
University of Colorado, DenverImmunoGen, Inc.RecruitingFallopian Tube Cancer | Peritoneal Cancer | Ovary CancerUnited States